# Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death

> **NCT01722942** · NA · UNKNOWN · sponsor: **InCor Heart Institute** · enrollment: 1100 (estimated)

## Conditions studied

- Chagas Cardiomyopathy
- Non-sustained Ventricular Tachycardia
- At Least 10 Points in Rassi Risk Score for Death

## Interventions

- **PROCEDURE:** ICD implantation
- **DRUG:** amiodarone hydrochloride

## Key facts

- **NCT ID:** NCT01722942
- **Lead sponsor:** InCor Heart Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10-06
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2021-08-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01722942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01722942, "Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01722942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*